臺灣紫芝活性代謝物之最適化生產與活性探討

Optimized Production and Functional Evaluation of Bioactive Metabolites from Ganoderma formosanum

10.6342/NTU201702288

許凱廸

臺灣紫芝 ； 美白活性 ； 酪胺酸酶薄膜層析平台 ； 美白藥物篩選 ； 胞外多醣體 ； β-葡聚醣 ； Ganoderma formosanum ； depigmenting activity ； tyrosinase-based TLC bioautography ； anti-melanogenic drug screening ； EPS ； β-glucan.

國立臺灣大學生物科技研究所學位論文

2017年

博士

鄭光成

英文

臺灣紫芝為臺灣特有種靈芝，約30年前在桃園地區的楓香樹上首次被發現。由於其新穎性，僅有少數研究證明其藥理潛力，目前研究較詳盡的為臺灣紫芝胞外多醣體的免疫調節與抗腫瘤活性。然而，臺灣紫芝胞外多醣體的液態深層醱酵之最適化生產條件尚未確立，且臺灣紫芝的潛在生理活性仍然未知。 本研究的主要目的為探討臺灣紫芝新穎之活性與增進其胞外多醣體之產量，方向分為三大部份: (1) 研究臺灣紫芝菌絲體萃取物之美白活性 (2) 開發一種結合酪胺酸酶與薄膜層析法的高通量美白藥物篩選平台，以利鑑定臺灣紫芝萃取物的美白活性成份 (3) 利用統計與數學模型，最適化生產臺灣紫芝胞外多醣體的液態培養條件。 臺灣紫芝菌絲體酒精萃取物之乙酸乙酯份化層 (GFE-EA) 相較於其它份化層具有最好的體外抑制酪胺酸酶活性，進一步在B16-F10細胞模式中也發現，GFE-EA透過抑制酪胺酸酶活性與其蛋白表現量的機制，來降低胞泌與胞內黑色素形成。進一步在斑馬魚模式中，發現GFE-EA僅需七份之一麴酸的劑量，便能達到同樣程度的抗黑色素形成效果，且具較低的副作用。以上結果顯示，GFE-EA作為化妝品應用的高度潛力。 為了分離純化GFE-EA中具有美白活性之成分，我們建立了一種酪胺酸酶薄膜層析平台，以利鑑定GFE-EA份化層中的活性組成。再者，此平台賦予研究人員同時進行活性分析與鑑定活性物質之可能。相較以酪胺酸酶活性分析比色法偵測麴酸，酪胺酸酶薄膜層析平台不僅具備較優越的藥物劑量偵測極限，也兼具較低的酵素使用量。此外，Gage R&R分析的結果顯示，此平台具可靠的重複性與再現性。因此，我們利用此平台，從數個GFE-EA份化層中篩選出兩個具抑制酪胺酸活性的份化層 (GFE-EA F4、F5)。值得注意的是，這兩個份化層在斑馬魚模式中同樣顯示抗黑色素形成的效果，證實酪胺酸酶薄膜層析平台在篩選抗黑色素形成之藥物的應用性。 在最適化胞外多醣體的生產部份。我們利用反應曲面法探討起始pH值、葡萄糖與酵母萃取物對於胞外多醣生產的影響，實行Box-Behnken design (BBD) 模型的三因子三階層分析後，發現最佳培養的條件為起始pH值5.3、葡萄糖 49.2克/每公升與酵母萃取物4.9克/每公升。利用此最適化生產條件，經九天的醱酵後，胞外多醣體的總產量達到833毫克/每公升，是使用未優化培養基的1.4倍產量，同時也是目前文獻報導中最高的產量紀錄。特別的是，被認為是多醣體活性來源的β-葡聚醣，在此胞外多醣體中的比例為53 ± 5.5%，顯示臺灣紫芝胞外多醣體擁有免疫調節活性之高度潛力。 以上研究不僅推翻一般認為菌絲體缺乏子實體才擁有特定活性的認知，同時也建立一個優越的酵素薄膜層析平台，使研究者能同時評估混合物樣品的活性與鑑定其活性成份。此外，這是首個闡明最適化臺灣紫芝多醣體生產條件的研究，提供未來大規劃工業化醱酵的基礎。總結來說，我們認為臺灣紫芝的活性代謝物，份別具有作為美白活性化妝品與免疫調節保健食品的潛力。

Ganoderma formosanum, an endemic Ganoderma (Lingzhi) species in Taiwan, was firstly identified from Formosan sweet gum (Liquidambar formosana) in Taoyuan County, Taiwan three decades ago. Currently, only few studies had demonstrated its pharmacological potential due to its novelty, among which the immune-modulation and anti-tumor effects of extracellular polysaccharide (EPS) is the most understood. However, optimization for the production of G. formosanum EPS in submerged fermentation has not yet been explored, and potential bioactivities of G. formosanum remain unknown. The specific aim of this study is to explore the frontiers of bioactivity possessed by G. formosanum and to ameliorate the yield of EPS. The present research is divided into three parts as follows: first, depigmenting activity of G. formosanum mycelium extract was studied rather than Lingzhi’s traditional uses. Second, a high-throughput tyrosinase-based TLC bioautography was developed to identify active ingredients responsible for anti-melanogenic activity of G. formosanum mycelium extract. Third, a collection of statistical and mathematical approaches was used to optimize the medium composition for EPS production in submerged fermentation. To screen depigmenting ingredients from G. formosanum, ethyl acetate fraction of G. formosanum mycelium ethanolic extract (GFE-EA) was demonstrated that exhibits the highest inhibitory activity toward cell-free tyrosinase compared with other fractions. Furthermore, the level of secreted and intracellular melanin of B16-F10 cells were reduced by GFE-EA through suppression of tyrosinase activity and its protein expression. Moreover, GFE-EA exerts similar depigmenting efficacy to kojic acid with lower dosage (approximately one-seventh of dose), but shows less adverse effect to zebrafish. It would appear that GFE-EA has great potential for application in the cosmetics industry. In order to purify and to isolate active compound(s) responsible for anti-melanogenic property of GFE-EA, we established a tyrosinase-based thin layer chromatography (TLC) to identify bioactive ingredients from fractions of GFE-EA, and this technique enable researchers to identify active compound(s) during functional assay. Compared with colorimetric tyrosinase activity assay, tyrosinase-based TLC not only showed better detection limit for kojic acid but also cost lower usage of enzyme. In addition, results of Gage R&R study indicated the repeatability and reproducibility of this platform are reliable. Accordingly, this platform was employed to screen fractions of GFE-EA exerting tyrosinase inhibitory activity, and two fractions (GFE-EA F4, F5) were obtained. Above all, it is worth noting that these fractions also showed depigmenting activity on zebrafish, verifying the applicability of tyrosinase-based TLC for anti-melanogenic drug screening. For optimization of EPS production, response surface methodology (RSM) was employed to study the effects of initial pH, glucose and yeast extract concentration on EPS yield. The optimum medium composition was found to be at initial pH 5.3, 49.2 g/L of glucose and 4.9 g/L of yeast extract by implementing a three-factor-three-level Box-Behnken design (BBD). After a 9-day fermentation with optimal conditions, the yield of EPS reached 833 mg/L, which is 1.4 fold-higher than that from basic medium, and it is the highest yield have been reported to date. Above all, the percentage of β-glucan, a well-recognized bioactive polysaccharide, in EPS was 53 ± 5.5%, suggesting G. formosanum EPS may possess potential immunomodulation activity. Altogether, these results not only subvert the general notion that mycelium lacks certain bioactivities, such as depigmenting activity, possessed by fruit bodies, but also provide a superior enzyme-based TLC platform to enable researchers to conduct functional assay and identify active compound(s) from tested mixture simultaneously. Furthermore, this is also the first research to optimize the culture conditions for G. formosanum EPS production, providing fundamental basis for industrial large-scale fermentation. In this study we argue that metabolites of G. formosanum may possess skin lightening and immunomodulation potential to be a cosmetic and nutraceutical, respectively.

1. Akbar, R., & Yam, W. K. (2011). Interaction of ganoderic acid on HIV related target: molecular docking studies. Bioinformation, 7(8), 413-417.
   連結：
2. Ali, A., Ashraf, Z., Kumar, N., Rafiq, M., Jabeen, F., Park, J. H., . . . Attri, P. (2016). Influence of plasma-activated compounds on melanogenesis and tyrosinase activity. Scientific Reports, 6. doi:ARTN 2177910.1038/srep21779
   連結：
3. Ates, G., Doktorova, T. Y., Pauwels, M., & Rogiers, V. (2014). Retrospective analysis of the mutagenicity/genotoxicity data of the cosmetic ingredients present on the Annexes of the Cosmetic EU legislation (200012). Mutagenesis, 29(2), 115-121. doi:10.1093/mutage/get068
   連結：
4. Bezerra, M. A., Santelli, R. E., Oliveira, E. P., Villar, L. S., & Escaleira, L. A. (2008). Response surface methodology (RSM) as a tool for optimization in analytical chemistry. Talanta, 76(5), 965-977. doi:10.1016/j.talanta.2008.05.019
   連結：
5. Bishop, K. S., Kao, C. H. J., Xu, Y. Y., Glucina, M. P., Paterson, R. R. M., & Ferguson, L. R. (2015). From 2000 years of Ganoderma lucidum to recent developments in nutraceuticals. Phytochemistry, 114, 56-65. doi:10.1016/j.phytochem.2015.02.015
   連結：
6. Bozena Waszkiewicz-Robak (2013). Spent brewer’s yeast and beta-glucans isolated from them as diet components modifying blood lipid metabolism disturbed by an atherogenic diet. InTech, DOI: 10.5772/51530.
   連結：
7. Brenner, M., & Hearing, V. J. (2008). The protective role of melanin against UV damage in human skin. Photochemistry and Photobiology, 84(3), 539-549. doi:10.1111/j.1751-1097.2007.00226.x
   連結：
8. Briggs, J. P. (2002). The zebrafish: A new model organism for integrative physiology. American Journal of Physiology-Regulatory Integrative and Comparative Physiology, 282(1), R3-R9.
   連結：
9. Camp, E., & Lardelli, M. (2001). Tyrosinase gene expression in zebrafish embryos. Development Genes and Evolution, 211(3), 150-153. doi:DOI 10.1007/s004270000125
   連結：
10. Carta, R. (1999). Solubilities of L-cystine, L-tyrosine, L-leucine, and glycine in their water solutions. Journal of Chemical and Engineering Data, 44(3), 563-567. doi:DOI 10.1021/je980225d
    連結：
11. Chan, G. C. F., Chan, W. K., & Sze, D. M. Y. (2009). The effects of beta-glucan on human immune and cancer cells. Journal of Hematology & Oncology, 2. doi:Artn 2510.1186/1756-8722-2-25
    連結：
12. Chang, C. J., Lin, C. S., Lu, C. C., Martel, J., Ko, Y. F., Ojcius, D. M., . . . Lai, H. C. (2015). Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nature Communications, 6. doi:ARTN 748910.1038/ncomms8489
    連結：
13. Chang, T. S. (2009). An updated review of tyrosinase inhibitors. International Journal of Molecular Sciences, 10(6), 2440-2475. doi:10.3390/ijms10062440
    連結：
14. Chang, Y. W., & Lu, T. J. (2004). Molecular characterization of polysaccharides in hot-water extracts of Ganoderma lucidum fruiting bodies. Journal of Food and Drug Analysis, 12(1), 59-67.
    連結：
15. Chanmee, T., Ontong, P., Konno, K., & Itano, N. (2014). Tumor-associated macrophages as major players in the tumor microenvironment. Cancers, 6(3), 1670-1690. doi:10.3390/cancers6031670
    連結：
16. Chen, N. H., Liu, J. W., & Zhong, J. J. (2010). Ganoderic acid T inhibits tumor invasion in vitro and in vivo through inhibition of MMP expression. Pharmacological Reports, 62(1), 150-163.
    連結：
17. Chen, S. D., Li, X. M., Yong, T. Q., Wang, Z. G., Su, J. Y., Jiao, C. W., . . . Yang, B. B. (2017). Cytotoxic lanostane-type triterpenoids from the fruiting bodies of Ganoderma lucidum and their structure-activity relationships. Oncotarget, 8(6), 10071-10084. doi:10.18632/oncotarget.14336
    連結：
18. Chen, S. Y., Chang, C. L., Chen, T. H., Chang, Y. W., & Lin, S. B. (2016). Colossolactone H, a new Ganoderma triterpenoid exhibits cytotoxicity and potentiates drug efficacy of gefitinib in lung cancer. Fitoterapia, 114, 81-91. doi:10.1016/j.fitote.2016.08.015
    連結：
19. Chen, W. C., Tseng, T. S., Hsiao, N. W., Lin, Y. L., Wen, Z. H., Tsai, C. C., . . . Tsai, K. C. (2015). Discovery of highly potent tyrosinase inhibitor, T1, with significant anti-melanogenesis ability by zebrafish in vivo assay and computational molecular modeling. Scientific Reports, 5. doi:ARTN 799510.1038/srep07995
    連結：
20. Chen, Y., Bicker, W. F., Wu, J. Y., Xie, M. Y., & Lindner, W. G. (2012). Simultaneous determination of 16 nucleosides and nucleobases by hydrophilic interaction chromatography and its application to the quality evaluation of Ganoderma. Journal of Agricultural and Food Chemistry, 60(17), 4243-4252. doi:10.1021/jf300076j
    連結：
21. Cheng, K. C. (2008). Skin color in fish and humans: Impacts on science and society. Zebrafish, 5(4), 237-242. doi:10.1089/zeb.2008.0577
    連結：
22. Cheng, K. C., Demirci, A., & Catchmark, J. M. (2010). Effects of plastic composite support and pH profiles on pullulan production in a biofilm reactor. Applied Microbiology and Biotechnology, 86(3), 853-861. doi:DOI 10.1007/s00253-009-2332-x
    連結：
23. Cheng, K. C., Ren, M., & Ogden, K. L. (2013). Statistical optimization of culture media for growth and lipid production of Chlorella protothecoides UTEX 250. Bioresource Technology, 128, 44-48. doi:10.1016/j.biortech.2012.09.085
    連結：
24. Cheng, S., & Sliva, D. (2015). Ganoderma lucidum for cancer treatment: we are close but still not there. Integrative Cancer Therapies, 14(3), 249-257. doi:10.1177/1534735414568721
    連結：
25. Cheng, Z. H., & Wu, T. (2013). TLC Bioautography: High throughput technique for screening of bioactive natural products. Combinatorial Chemistry & High Throughput Screening, 16(7), 531-549.
    連結：
26. Chien, C. C., Tsai, M. L., Chen, C. C., Chang, S. J., & Tseng, C. H. (2008). Effects on tyrosinase activity by the extracts of Ganoderma lucidum and related
    連結：
27. mushrooms. Mycopathologia, 166(2), 117-120. doi:10.1007/s11046-008-9128-x
    連結：
28. Choi, T. Y., Kim, J. H., Ko, D. H., Kim, C. H., Hwang, J. S., Ahn, S., . . . Yoon, T. J. (2007). Zebrafish as a new model for phenotype-based screening of melanogenic regulatory compounds. Pigment Cell Research, 20(2), 120-127. doi:10.1111/j.1600-0749.2007.00365.x
    連結：
29. Deepalakshmi, K., Mirunalini, S., Krishnaveni, M., & Arulmozhi, V. (2013). In vitro and in vivo antioxidant potentials of an ethanolic extract of Ganoderma lucidum in rat mammary carcinogenesis. Chinese Journal of Natural Medicines, 11(6), 621-627. doi:10.3724/Sp.J.1009.2013.00621
    連結：
30. Di Giouanni, S., Borloz, A., Urbain, A., Marston, A., Hostettmann, K., Carrupt, P. A., & Reist, M. (2008). In vitro screening assays to identify natural or synthetic acetylcholinesterase inhibitors: Thin layer chromatography versus microplate methods. European Journal of Pharmaceutical Sciences, 33(2), 109-119. doi:10.1016/j.ejps.2007.10.004
    連結：
31. Ding, H. Y., Chang, T. S., Shen, H. C., & Tai, S. S. K. (2011). Murine tyrosinase Inhibitors from Cynanchum bungei and evaluation of in vitro and in vivo depigmenting activity. Experimental Dermatology, 20(9), 720-724. doi:10.1111/j.1600-0625.2011.01302.x
    連結：
32. Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J., . . . White, N. J. (2009). Artemisinin resistance in Plasmodium falciparum malaria. New England Journal of Medicine, 361(5), 455-467. doi:DOI 10.1056/NEJMoa0808859
    連結：
33. Elinav, E., Nowarski, R., Thaiss, C. A., Hu, B., Jin, C. C., & Flavell, R. A. (2013). Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nature Reviews Cancer, 13(11), 759-771. doi:10.1038/nrc3611
    連結：
34. Elmore, S. (2007). Apoptosis: A review of programmed cell death. Toxicologic Pathology, 35(4), 495-516. doi:10.1080/01926230701320337
    連結：
35. Fang, Q. H., Tang, Y. J., & Zhong, J. J. (2002). Significance of inoculation density control in production of polysaccharide and ganoderic acid by submerged culture of Ganoderma lucidum. Process Biochemistry, 37(12), 1375-1379. doi:Pii S0032-9592(02)00017-1Doi 10.1016/S0032-9592(02)00017-1
    連結：
36. Fang, Q. H., & Zhong, J. J. (2002a). Effect of initial pH on production of ganoderic acid and polysaccharide by submerged fermentation of Ganoderma lucidum. Process Biochemistry, 37(7), 769-774. doi:Doi 10.1016/S0032-9592(01)00278-3
    連結：
37. Fang, Q. H., & Zhong, J. J. (2002b). Submerged fermentation of higher fungus Ganoderma lucidum for production of valuable bioactive metabolites-ganoderic acid and polysaccharide. Biochemical Engineering Journal, 10(1), 61-65. doi:Pii S1369-703x(01)00158-9Doi 10.1016/S1369-703x(01)00158-9
    連結：
38. Fang, Q. H., & Zhong, J. J. (2002c). Two-stage culture process for improved production of ganoderic acid by liquid fermentation of higher fungus Ganoderma lucidum. Biotechnology Progress, 18(1), 51-54. doi:Doi 10.1021/Bp010136g
    連結：
39. Feitelson, D. G. (2015). From Repeatability to Reproducibility and Corroboration. SIGOPS Oper. Syst. Rev., 49(1), 3-11. doi:10.1145/2723872.2723875
    連結：
40. Fernando, K. M. E. P. (2008). The host preference of a Ganoderma lucidum strain for three tree species of Fabaceae family; Cassia nodosa, Cassia fistula and Delonix regia. Journal of the National Science Foundation of Sri Lanka, 36(4), 323-326.
    連結：
41. Ferreira, I. C. F. R., Heleno, S. A., Reis, F. S., Stojkovic, D., Queiroz, M. J. R. P., Vasconcelos, M. H., & Sokovic, M. (2015). Chemical features of Ganoderma polysaccharides with antioxidant, antitumor and antimicrobial activities. Phytochemistry, 114, 38-55. doi:10.1016/j.phytochem.2014.10.011
    連結：
42. Flemming, H. C., & Wingender, J. (2010). The biofilm matrix. Nature Reviews Microbiology, 8(9), 623-633. doi:10.1038/nrmicro2415
    連結：
43. Fraga, I., Coutinho, J., Bezerra, R. M., Dias, A. A., Marques, G., & Nunes, F. M. (2014). Influence of culture medium growth variables on Ganoderma lucidum exopolysaccharides structural features. Carbohydrate Polymers, 111, 936-946. doi:10.1016/j.carbpol.2014.05.047
    連結：
44. Gan, K. H., Fann, Y. F., Hsu, S. H., Kuo, K. W., & Lin, C. N. (1998). Mediation of the cytotoxicity of lanostanoids and steroids of Ganoderma tsugae through apoptosis and cell cycle. Journal of Natural Products, 61(4), 485-487. doi:Doi 10.1021/Np9704664
    連結：
45. Gao, J. L., Leung, K. S. Y., Wang, Y. T., Lai, C. M., Li, S. P., Hu, L. E., . . . Yu, Z. L. (2007). Qualitative and quantitative analyses of nucleosides and nucleobases in Ganoderma spp. by HPLC-DAD-MS. Journal of Pharmaceutical and Biomedical Analysis, 44(3), 807-811. doi:10.1016/j.jpba.2007.03.012
    連結：
46. Gao, Y., Dai, X., Chen, G., Ye, J., & Zhou, S. (2003). A Randomized, Placebo-Controlled, Multicenter Study of Ganoderma lucidum (W.Curt.:Fr.) Lloyd (Aphyllophoromycetideae) Polysaccharides in Patients with Advanced Lung Cancer. 5(4), 14. doi:10.1615/InterJMedicMush.v5.i4.40
    連結：
47. Gao, Y., Lan, J., Dai, X., Ye, J., & Zhou, S. (2004). A Phase I/II Study of Ling Zhi Mushroom Ganoderma lucidum (W.Curt.:Fr.) Lloyd (Aphyllophoromycetideae) Extract in Patients with Type II Diabetes Mellitus. 6(1), 8. doi:10.1615/IntJMedMushr.v6.i1.30
    連結：
48. Gao, Y., Zhou, S., Chen, G., Dai, X., & Ye, J. (2002). A Phase I/II study of a Ganoderma lucidum (Curt.: Fr.) P. Karst. extract (Ganopoly) in patients with advanced cancer. 4(3), 8. doi:10.1615/IntJMedMushr.v4.i3.30
    連結：
49. Gao, Y., Zhou, S., Chen, G., Dai, X., Ye, J., & Gao, H. (2002). A Phase I/II study of a Ganoderma lucidum (Curt.: Fr.) P. Karst. (Ling Zhi, Reishi Mushroom) extract in patients with chronic hepatitis. 4(4), 7.doi:10.1615/IntJMedMushr.v4.i4.50
    連結：
50. Gao, Y. H., Zhou, S. F., Jiang, W. Q., Huang, M., & Dai, X. H. (2003). Effects of Ganopoly (R) (A Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunological Investigations, 32(3), 201-215. doi:Doi 10.1081/Imm-120022979
    連結：
51. Gao, Z., Moore, T., Smith, A. P., Doub, W., Westenberger, B., & Buhse, L. (2007). Gauge repeatability and reproducibility for accessing variability during dissolution testing: A technical note. AAPS PharmSciTech, 8(4), 11-15. doi:10.1208/pt0804082
    連結：
52. Garcia, P., & Furlan, R. L. E. (2015). Multiresponse optimisation applied to the development of a TLC autography for the detection of tyrosinase inhibitors. Phytochemical Analysis, 26(4), 287-292. doi:10.1002/pca.2562
    連結：
53. Germanas, J. P., Wang, S. G., Miner, A., Hao, W., & Ready, J. M. (2007). Discovery of small-molecule inhibitors of tyrosinase. Bioorganic & Medicinal Chemistry Letters, 17(24), 6871-6875. doi:10.1016/j.bmcl.2007.10.014
    連結：
54. Gokce, E. C., Kahveci, R., Atanur, O. M., Gurer, B., Aksoy, N., Gokce, A., . . . Kahveci, O. (2015). Neuroprotective effects of Ganoderma lucidum polysaccharides against traumatic spinal cord injury in rats. Injury-International Journal of the Care of the Injured, 46(11), 2146-2155. doi:10.1016/j.injury.2015.08.017
    連結：
55. Grundemann, C., Garcia-Kaufer, M., Sauer, B., Scheer, R., Merdivan, S., Bettin, P., . . . Lindequist, U. (2015). Comparative chemical and biological investigations of beta-glucan-containing products from shiitake mushrooms. Journal of Functional Foods, 18, 692-702. doi:10.1016/j.jff.2015.08.022
    連結：
56. Hajjaj, H., Mace, C., Roberts, M., Niederberger, P., & Fay, L. B. (2005). Effect of 26-oxygenosterols from Ganoderma lucidum and their activity as cholesterol synthesis inhibitors. Applied and Environmental Microbiology, 71(7), 3653-3658. doi:Doi 10.1128/Aem.71.7.3653-3658.2005
    連結：
57. Hamdan, D., Leboeuf, C., Pereira, C., Jourdan, N., Verneuil, L., Bousquet, G., & Janin, A. (2015). A digestive allergic reaction with hypereosinophilia imputable to docetaxel in a breast cancer patient: a case report. BMC Cancer, 15, 993. doi:10.1186/s12885-015-2008-0
    連結：
58. Hashim, S. N. N. S., Schwarz, L. J., Danylec, B., Mitri, K., Yang, Y. Z., Boysen, R. I., & Hearn, M. T. W. (2016). Recovery of ergosterol from the medicinal mushroom, Ganoderma tsugae var. Janniae, with a molecularly imprinted polymer derived from a cleavable monomer-template composite. Journal of Chromatography A, 1468, 1-9. doi:10.1016/j.chroma.2016.09.004
    連結：
59. Hassan, A. M. S. (2012). TLC bioautographic method for detecting lipase inhibitors. Phytochemical Analysis, 23(4), 405-407. doi:10.1002/pca.1372
    連結：
60. Hitchcock, D. I. (1924). The solubility of tyrosine in acid and in alkali. Journal of General Physiology, 6(6), 747-757. doi:DOI 10.1085/jgp.6.6.747
    連結：
61. Hsieh, C., Tseng, M. H., & Liu, C. J. (2006). Production of polysaccharides from Ganoderma lucidum (CCRC 36041) under limitations of nutrients. Enzyme and Microbial Technology, 38(1-2), 109-117. doi:10.1016/j.enzmictec.2005.05.004
    連結：
62. Hsin, I. L., Ou, C. C., Wu, M. F., Jan, M. S., Hsiao, Y. M., Lin, C. H., & Ko, J. L. (2015). GMI, an Immunomodulatory Protein from Ganoderma microsporum, potentiates cisplatin-induced apoptosis via autophagy in lung cancer cells. Molecular Pharmaceutics, 12(5), 1534-1543. doi:10.1021/mp500840z
    連結：
63. Hsu, K. D., Wu, S. P., Lin, S. P., Lum, C. C., & Cheng, K. C. (2017). Enhanced active extracellular polysaccharide production from Ganoderma formosanum using computational modeling. Journal of Food and Drug Analysis, 0(0). doi:10.1016/j.jfda.2016.12.006
    連結：
64. Hsu, K. D., Chen, H. J., Wang, C. S., Lum, C. C., Wu, S. P., Lin, S. P., & Cheng, K. C. (2016). Extract of Ganoderma formosanum Mycelium as a highly potent tyrosinase inhibitor. Scientific Reports, 6. doi:ARTN 3285410.1038/srep32854
    連結：
65. Hu, S. T., Zheng, Z. P., Zhang, X. C., Chen, F., & Wang, M. F. (2015). Oxyresveratrol and trans-dihydromorin from the twigs of Cudrania tricuspidata as hypopigmenting agents against melanogenesis. Journal of Functional Foods, 13, 375-383. doi:10.1016/j.jff.2015.01.010
    連結：
66. Huang, L., Sun, F., Liang, C. Y., He, Y. X., Bao, R., Liu, L. X., & Zhou, C. Z. (2009). Crystal structure of LZ-8 from the medicinal fungus Ganoderma lucidium. Proteins-Structure Function and Bioinformatics, 75(2), 524-527. doi:10.1002/prot.22346
    連結：
67. Huang, S. C., Mao, J. X., Ding, K., Zhou, Y., Zeng, X. L., Yang, W. J., . . . Pei, G. (2017). Polysaccharides from Ganoderma lucidum promote cognitive function and neural progenitor proliferation in mouse model of Alzheimer's disease. Stem Cell Reports, 8(1), 84-94. doi:10.1016/j.stemcr.2016.12.007
    連結：
68. Iozumi, K., Hoganson, G. E., Pennella, R., Everett, M. A., & Fuller, B. B. (1993). Role of tyrosinase as the determinant of pigmentation in cultured human melanocytes. Journal of Investigative Dermatology, 100(6), 806-811. doi:DOI 10.1111/1523-1747.ep12476630
    連結：
69. Jesionek, W., Moricz, A. M., Alberti, A., Ott, P. G., Kocsis, B., Horvath, G., & Choma, I. M. (2015). TLC-direct bioautography as a bioassay guided method for investigation of antibacterial compounds in hypericum perforatum L. Journal of Aoac International, 98(4), 1013-1020. doi:10.5740/jaoacint.14-233
    連結：
70. Jo, W. S., Cho, Y. J., Cho, D. H., Park, S. D., Yoo, Y. B., & Seok, S. J. (2009). Culture conditions for the mycelial growth of Ganoderma applanatum. Mycobiology, 37(2), 94-102.
    連結：
71. Kalahroudi, V. G., Kamalidehghan, B., Kani, A. A., Aryani, O., Tondar, M., Ahmadipour, F., . . . Houshmand, M. (2014). Two novel tyrosinase (TYR) gene mutations with pathogenic impact on oculocutaneous albinism type 1 (OCA1). Plos One, 9(9). doi:ARTN e10665610.1371/journal.pone.0106656
    連結：
72. Kang, D., Mutakin, M., & Levita, J. (2015). Computational study of triterpenoids of Ganoderma lucidum with aspartic protease enzymes for discovering HIV-1 and plasmepsin inhibitors. 2015, 7(1). doi:10.5539/ijc.v7n1p62
    連結：
73. Karlsson, J., von Hofsten, J., & Olsson, P. E. (2001). Generating transparent zebrafish: A refined method to improve detection of gene expression during embryonic development. Marine Biotechnology, 3(6), 522-527. doi:DOI 10.1007/s1012601-0053-4
    連結：
74. Kawagishi, H., Fukuhara, F., Sazuka, M., Kawashima, A., Mitsubori, T., & Tomita, T. (1993). 5'-deoxy-5'-methylsulphinyladenosine, a platelet-aggregation inhibitor from Ganoderma lucidum. Phytochemistry, 32(2), 239-241. doi:Doi 10.1016/S0031-9422(00)94974-4
    連結：
75. Kim, H. M., Park, M. K., & Yun, J. W. (2006). Culture pH affects exopolysaccharide production in submerged mycelial culture of Ganoderma lucidum. Applied Biochemistry and Biotechnology, 134(3), 249-262. doi:Doi 10.1385/Abab:134:3:249
    連結：
76. Kim, J. H., Baek, S. H., Kim, D. H., Choi, T. Y., Yoon, T. J., Hwang, J. S., . . . Lee, C. H. (2008). Downregulation of melanin synthesis by haginin A and its application to in vivo lightening model. Journal of Investigative Dermatology, 128(5), 1227-1235. doi:10.1038/sj.jid.5701177
    連結：
77. Kim, J. K., Kim, M., Cho, S. G., Kim, M. K., Kim, S. W., & Lim, Y. H. (2010). Biotransformation of mulberroside A from Morus alba results in enhancement of tyrosinase inhibition. Journal of Industrial Microbiology & Biotechnology, 37(6), 631-637. doi:10.1007/s10295-010-0722-9
    連結：
78. Klupp, N. L., Kiat, H., Bensoussan, A., Steiner, G. Z., & Chang, D. H. (2016). A double-blind, randomised, placebo-controlled trial of Ganoderma lucidum for the treatment of cardiovascular risk factors of metabolic syndrome. Scientific Reports, 6. doi:ARTN 2954010.1038/srep29540
    連結：
79. Lakornwong, W., Kanokmedhakul, K., Kanokmedhakul, S., Kongsaeree, P., Prabpai, S., Sibounnavong, P., & Soytong, K. (2014). Triterpene lactones from cultures of Ganoderma sp. KM01. Journal of Natural Products, 77(7), 1545-1553. doi:10.1021/np400846k
    連結：
80. Langheinrich, U. (2003). Zebrafish: a new model on the pharmaceutical catwalk. Bioessays, 25(9), 904-912. doi:10.1002/bies.10326
    連結：
81. Lee, K. M., Lee, S. Y., & Lee, H. Y. (1999). Bistage control of pH for improving exopolysaccharide production from mycelia of Ganoderma lucidum in an air-lift fermentor. Journal of Bioscience and Bioengineering, 88(6), 646-650. doi:Doi 10.1016/S1389-1723(00)87094-2
    連結：
82. Lee, S. J., Chan, T. H., Chen, T. C., Liao, B. K., Hwang, P. P., & Lee, H. (2008). LPA(1) is essential for lymphatic vessel development in zebrafish. Faseb Journal, 22(10), 3706-3715. doi:10.1096/fj.08-106088
    連結：
83. Lee, W. Y., Park, Y., Ahn, J. K., Ka, K. H., & Park, S. Y. (2007). Factors influencing the production of endopolysaccharide and exopolysaccharide from Ganoderma applanatum. Enzyme and Microbial Technology, 40(2), 249-254. doi:DOI 10.1016/j.enzmictec.2006.04.009
    連結：
84. Li, A. M., Shuai, X. Y., Jia, Z. J., Li, H. Y., Liang, X. B., Su, D. M., & Guo, W. H. (2015). Ganoderma lucidum polysaccharide extract inhibits hepatocellular carcinoma growth by downregulating regulatory T cells accumulation and function by inducing microRNA-125b. Journal of Translational Medicine, 13. doi:ARTN 10010.1186/s12967-015-0465-5
    連結：
85. Li, E. K., Tam, L. S., Wong, C. K., Li, W. C., Lam, C. W. K., Wachtel-Galor, S., . . . Tomlinson, B. (2007). Safety and efficacy of Ganoderma lucidum (Lingzhi) and San miao San supplementation in patients with rheumatoid arthritis: A double-blind, randomized, placebo-controlled pilot trial. Arthritis & Rheumatism-Arthritis Care & Research, 57(7), 1143-1150. doi:10.1002/art.22994
    連結：
86. Li, J. Q., Zhang, J. H., Chen, H. M., Chen, X. D., Lan, J., & Liu, C. (2013). Complete mitochondrial genome of the medicinal mushroom Ganoderma lucidum. Plos One, 8(8). doi:ARTN e7203810.1371/journal.pone.0072038
    連結：
87. Liao, S. F., Liang, C. H., Ho, M. Y., Hsu, T. L., Tsai, T. I., Hsieh, Y. S. Y., . . . Wong, C. H. (2013). Immunization of fucose-containing polysaccharides from Reishi mushroom induces antibodies to tumor-associated Globo H-series epitopes. Proceedings of the National Academy of Sciences of the United States of America, 110(34), 13809-13814. doi:DOI 10.1073/pnas.1312457110
    連結：
88. Likhitwitayawuid, K., & Sritularak, B. (2001). A new dimeric stilbene with tyrosinase inhibitiory activity from Artocarpus gomezianus. Journal of Natural Products, 64(11), 1457-1459. doi:10.1021/np0101806
    連結：
89. Lin, C. C., Yu, Y. L., Shih, C. C., Liu, K. J., Ou, K. L., Hong, L. Z., . . . Chu, C. L. (2011). A novel adjuvant Ling Zhi-8 enhances the efficacy of DNA cancer vaccine by activating dendritic cells. Cancer Immunology Immunotherapy, 60(7), 1019-1027. doi:10.1007/s00262-011-1016-4
    連結：
90. Lin, J. M., Lin, C. C., Chen, M. F., Ujiie, T., & Takada, A. (1995). Radical scavenger and antihepatotoxic activity of Ganoderma formosanum, Ganoderma lucidum and Ganoderma neo-japonicum. Journal of Ethnopharmacology, 47(1), 33-41. doi:Doi 10.1016/0378-8741(95)01251-8
    連結：
91. Lin, T. Y., & Hsu, H. Y. (2016). Ling Zhi-8 reduces lung cancer mobility and metastasis through disruption of focal adhesion and induction of MDM2-mediated Slug degradation. Cancer Letters, 375(2), 340-348. doi:10.1016/j.canlet.2016.03.018
    連結：
92. Liu, C. D., Dunkin, D., Lai, J., Song, Y., Ceballos, C., Benkov, K., & Li, X. M. (2015). Anti-inflammatory Effects of Ganoderma lucidum triterpenoid in human Crohn's disease associated with downregulation of NF-kappa B signaling. Inflammatory Bowel Diseases, 21(8), 1918-1925. doi:10.1097/Mib.0000000000000439
    連結：
93. Liu, C. D., Yang, N., Song, Y., Wang, L. X., Zi, J. C., Zhang, S. W., . . . Li, X. M. (2015). Ganoderic acid C-1 isolated from the anti-asthma formula, ASHMI (TM) suppresses TNF-alpha production by mouse macrophages and peripheral blood mononuclear cells from asthma patients. International Immunopharmacology, 27(2), 224-231. doi:10.1016/j.intimp.2015.05.018
    連結：
94. Liu, J., Shimizu, K., Konishi, F., Kumamoto, S., & Kondo, R. (2007). The anti-androgen effect of ganoderol B isolated from the fruiting body of Ganoderma lucidum. Bioorganic & Medicinal Chemistry, 15(14), 4966-4972. doi:DOI 10.1016/j.bmc.2007.04.036
    連結：
95. Liu, J., Shiono, J., Shimizu, K., Kukita, A., Kukita, T., & Kondo, R. (2009). Ganoderic acid DM: Anti-androgenic osteoclastogenesis inhibitor. Bioorganic & Medicinal Chemistry Letters, 19(8), 2154-2157. doi:10.1016/j.bmcl.2009.02.119
    連結：
96. Madeo, F., Herker, E., Wissing, S., Jungwirth, H., Eisenberg, T., & Frohlich, K. U. (2004). Apoptosis in yeast. Current Opinion in Microbiology, 7(6), 655-660. doi:10.1016/j.mib.2004.10.012
    連結：
97. Martinez, F. O., & Gordon, S. (2014). The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep, 6, 13. doi:10.12703/P6-13
    連結：
98. Meng, L. Z., Xie, J., Lv, G. P., Hu, D. J., Zhao, J., Duan, J. A., & Li, S. P. (2014). A comparative study on immunomodulatory activity of polysaccharides from two official species of Ganoderma (Lingzhi). Nutrition and Cancer-an International Journal, 66(7), 1124-1131. doi:10.1080/01635581.2014.948215
    連結：
99. Ohbayashi, N., & Fukuda, M. (2012). Role of Rab family GTPases and their effectors in melanosomal logistics. Journal of Biochemistry, 151(4), 343-351. doi:10.1093/jb/mvs009
    連結：
100. Ou, C. C., Hsiao, Y. M., Hou, T. Y., Wu, M. F., & Ko, J. L. (2015). Fungal immunomodulatory proteins alleviate docetaxel-induced adverse effects. Journal of Functional Foods, 19, 451-463. doi:10.1016/j.jff.2015.09.042
     連結：
101. Pandey, S., Sree, A., Dash, S. S., & Sethi, D. P. (2013). A novel method for screening beta-glucosidase inhibitors. Bmc Microbiology, 13. doi:Artn 5510.1186/1471-2180-13-55
     連結：
102. Papinutti, L. (2010). Effects of nutrients, pH and water potential on exopolysaccharides production by a fungal strain belonging to Ganoderma lucidum complex. Bioresource Technology, 101(6), 1941-1946. doi:10.1016/j.biortech.2009.09.076
     連結：
103. Park, C. B., & Lee, S. B. Ammonia production from yeast extract and its effect on growth of the hyperthermophilic archaeonSulfolobus solfataricus. Biotechnology and Bioprocess Engineering, 3(2), 115-118. doi:10.1007/bf02932514
     連結：
104. Park, C. B., Ryu, D. D. Y., & Lee, S. B. (2003). Inhibitory effect of L-pyroglutamate on extremophiles: correlation with growth temperature and pH. Fems Microbiology Letters, 221(2), 187-190. doi:10.1016/S0378-1097(03)00213-1
     連結：
105. Parvez, S., Kang, M. K., Chung, H. S., Cho, C. W., Hong, M. C., Shin, M. K., & Bae, H. (2006). Survey and mechanism of skin depigmenting and lightening agents. Phytotherapy Research, 20(11), 921-934. doi:10.1002/ptr.1954
     連結：
106. Peng, L. H., Xu, S. Y., Shan, Y. H., Wei, W., Liu, S., Zhang, C. Z., . . . Gao, J. Q. (2014). Sequential release of salidroside and paeonol from a nanosphere-hydrogel system inhibits ultraviolet B-induced melanogenesis in guinea pig skin. Int J Nanomedicine, 9, 1897-1908. doi:10.2147/IJN.S59290
     連結：
107. Peterson, R. T., Link, B. A., Dowling, J. E., & Schreiber, S. L. (2000). Small molecule developmental screens reveal the logic and timing of vertebrate development. Proceedings of the National Academy of Sciences of the United States of America, 97(24), 12965-12969. doi:DOI 10.1073/pnas.97.24.12965
     連結：
108. Pi, C. C., Chu, C. L., Lu, C. Y., Zhuang, Y. J., Wang, C. L., Yu, Y. H., . . . Chen, C. J. (2014). Polysaccharides from Ganoderma formosanum function as a Th1 adjuvant and stimulate cytotoxic T cell response in vivo. Vaccine, 32(3), 401-408. doi:DOI 10.1016/j.vaccine.2013.11.027
     連結：
109. Postemsky, P. D., Bidegain, M. A., Gonzalez-Matute, R., Figlas, N. D., & Cubitto, M. A. (2017). Pilot-scale bioconversion of rice and sunflower agro-residues into medicinal mushrooms and laccase enzymes through solid-state fermentation with Ganoderma lucidum. Bioresource Technology, 231, 85-93. doi:10.1016/j.biortech.2017.01.064
     連結：
110. Ramsden, C. A., & Riley, P. A. (2014). Tyrosinase: The four oxidation states of the active site and their relevance to enzymatic activation, oxidation and inactivation. Bioorganic & Medicinal Chemistry, 22(8), 2388-2395. doi:10.1016/j.bmc.2014.02.048
     連結：
111. Russell, R., & Paterson, M. (2006). Ganoderma - A therapeutic fungal biofactory. Phytochemistry, 67(18), 1985-2001. doi:DOI 10.1016/j.phytochem.2006.07.004
     連結：
112. Scholz, S. (2013). Zebrafish embryos as an alternative model for screening of drug-induced organ toxicity. Archives of Toxicology, 87(5), 767-769. doi:10.1007/s00204-013-1044-2
     連結：
113. Scholz, S., Sela, E., Blaha, L., Braunbeck, T., Galay-Burgos, M., Garcia-Franco, M., . . . Winter, M. J. (2013). A European perspective on alternatives to animal testing for environmental hazard identification and risk assessment. Regulatory Toxicology and Pharmacology, 67(3), 506-530. doi:10.1016/j.yrtph.2013.10.003
     連結：
114. Seo, S. Y., Sharma, V. K., & Sharma, N. (2003). Mushroom tyrosinase: Recent prospects. Journal of Agricultural and Food Chemistry, 51(10), 2837-2853. doi:10.1021/jf020826f
     連結：
115. Shi, L. A., Ren, A., Mu, D. S., & Zhao, M. W. (2010). Current progress in the study on biosynthesis and regulation of ganoderic acids. Applied Microbiology and Biotechnology, 88(6), 1243-1251. doi:10.1007/s00253-010-2871-1
     連結：
116. Shimizu, A., Yano, T., Saito, Y., & Inada, Y. (1985). Isolation of an Inhibitor of Platelet-Aggregation from a Fungus, Ganoderma lucidum. Chemical & Pharmaceutical Bulletin, 33(7), 3012-3015.
     連結：
117. Shin, J. T., & Fishman, M. C. (2002). From zebrafish to human: Modular medical models. Annual Review of Genomics and Human Genetics, 3, 311-340. doi:10.1146/annurev.genom.3.031402.131506
     連結：
118. Siegrist, W., & Eberle, A. N. (1986). In situ melanin assay for MSH using mouse B16 melanoma cells in culture. Analytical Biochemistry, 159(1), 191-197. doi:http://dx.doi.org/10.1016/0003-2697(86)90327-1
     連結：
119. Singhania, R. R., Sukumaran, R. K., Patel, A. K., Larroche, C., & Pandey, A. (2010). Advancement and comparative profiles in the production technologies using solid-state and submerged fermentation for microbial cellulases. Enzyme and Microbial Technology, 46(7), 541-549. doi:10.1016/j.enzmictec.2010.03.010
     連結：
120. Slominski, A., Tobin, D. J., Shibahara, S., & Wortsman, J. (2004). Melanin pigmentation in mammalian skin and its hormonal regulation. Physiological Reviews, 84(4), 1155-1228. doi:10.1152/physrev.00044.2003
     連結：
121. Straub, K. L., Benz, M., & Schink, B. (2001). Iron metabolism in anoxic environments at near neutral pH. Fems Microbiology Ecology, 34(3), 181-186. doi:DOI 10.1111/j.1574-6941.2001.tb00768.x
     連結：
122. Sun, L. X., Lin, Z. B., Lu, J., Li, W. D., Niu, Y. D., Sun, Y., . . . Duan, X. S. (2017). The improvement of M1 polarization in macrophages by glycopeptide derived from Ganoderma lucidum. Immunol Res, 65(3), 658-665. doi:10.1007/s12026-017-8893-3
     連結：
123. Sung, J. H., Park, S. H., Seo, D. H., Lee, J. H., Hong, S. W., & Hong, S. S. (2009). Antioxidative and skin-whitening effect of an aqueous extract of Salicornia herbacea. Bioscience Biotechnology and Biochemistry, 73(3), 552-556. doi:10.1271/bbb.80601
     連結：
124. Tai, S. S. K., Lin, C. G., Wu, M. H., & Chang, T. S. (2009). Evaluation of depigmenting activity by 8-hydroxydaidzein in mouse B16 melanoma cells and human volunteers. International Journal of Molecular Sciences, 10(10), 4257-4266. doi:10.3390/ijms10104257
     連結：
125. Tang, Y. J., Zhang, W., Liu, R. S., Zhu, L. W., & Zhong, J. J. (2011). Scale-up study on the fed-batch fermentation of Ganoderma lucidum for the hyperproduction of ganoderic acid and Ganoderma polysaccharides. Process Biochemistry, 46(1), 404-408. doi:10.1016/j.procbio.2010.08.013
     連結：
126. Tang, Y. J., Zhang, W., & Zhong, J. J. (2009). Performance analyses of a pH-shift and DOT-shift integrated fed-batch fermentation process for the production of ganoderic acid and Ganoderma polysaccharides by medicinal mushroom Ganoderma lucidum. Bioresource Technology, 100(5), 1852-1859. doi:10.1016/j.biortech.2008.10.005
     連結：
127. Tang, Y. J., & Zhong, J. J. (2003). Role of oxygen supply in submerged fermentation of Ganoderma lucidum for production of Ganoderma polysaccharide and ganoderic acid. Enzyme and Microbial Technology, 32(3-4), 478-484. doi:Doi 10.1016/S0141-0229(02)00338-1
     連結：
128. Tao, J., & Feng, K. Y. (1990). Experimental and clinical studies on inhibitory effect of Ganoderma lucidum on platelet aggregation. J Tongji Med Univ, 10(4), 240-243.
     連結：
129. Taylor, P. R., Tsoni, S. V., Willment, J. A., Dennehy, K. M., Rosas, M., Findon, H., . . . Brown, G. D. (2007). Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nature Immunology, 8(1), 31-38. doi:DOI 10.1038/ni1408
     連結：
130. Tun, T. C., & Tou, C. (1984). Ganoderma formosanum Sp-Nov on Formosan Sweet Gum in Taiwan. Transactions of the British Mycological Society, 82(Jun), 731-733.
     連結：
131. Wang, C. H., Hsieh, S. C., Wang, H. J., Chen, M. L., Lin, B. F., Chiang, B. H., & Lu, T. J. (2014). Concentration variation and molecular characteristics of soluble (1,3;1,6)-beta-D-Glucans in submerged cultivation products of Ganoderma lucidum Mycelium. Journal of Agricultural and Food Chemistry, 62(3), 634-641. doi:Doi 10.1021/Jf404533b
     連結：
132. Wang, C. L., Lu, C. Y., Hsueh, Y. C., Liu, W. H., & Chen, C. J. (2014). Activation of antitumor immune responses by Ganoderma formosanum polysaccharides in tumor-bearing mice. Applied Microbiology and Biotechnology, 98(22), 9389-9398. doi:10.1007/s00253-014-6027-6
     連結：
133. Wang, C. L., Lu, C. Y., Pi, C. C., Zhuang, Y. J., Chu, C. L., Liu, W. H., & Chen, C. J. (2012). Extracellular polysaccharides produced by Ganoderma formosanum stimulate macrophage activation via multiple pattern-recognition receptors. Bmc Complementary and Alternative Medicine, 12. doi:Artn 119
     連結：
134. Doi 10.1186/1472-6882-12-119
     連結：
135. Wang, C. L., Pi, C. C., Kuo, C. W., Zhuang, Y. J., Khoo, K. H., Liu, W. H., & Chen, C. J. (2011). Polysaccharides purified from the submerged culture of Ganoderma formosanum stimulate macrophage activation and protect mice against Listeria monocytogenes infection. Biotechnology Letters, 33(11), 2271-2278. doi:DOI 10.1007/s10529-011-0697-2
     連結：
136. Wang, H. Q., Zhong, J. J., & Yu, J. T. (1997). Enhanced production of taxol in suspension cultures of Taxus chinensis by controlling inoculum size. Biotechnology Letters, 19(4), 353-355. doi:Doi 10.1023/A:1018355002041
     連結：
137. Wang, J. G., Yuan, Y. H., & Yue, T. L. (2014). Immunostimulatory activities of beta-D-glucan from Ganoderma lucidum. Carbohydrate Polymers, 102, 47-54. doi:10.1016/j.carbpol.2013.10.087
     連結：
138. Wang, N., Liang, H. W., & Zen, K. (2014). Molecular mechanisms that influence the macrophage M1-M2 polarization balance. Frontiers in Immunology, 5. doi:ARTN 61410.3389/fimmu.2014.00614
     連結：
139. Wang, X. M., Yang, M., Guan, S. H., Liu, R. X., Xia, J. M., Bi, K. S., & Guo, D. A. (2006). Quantitative determination of six major triterpenoids in Ganoderma lucidum and related species by high performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis, 41(3), 838-844. doi:10.1016/j.jpba.2006.01.053
     連結：
140. Wangthong, S., Tonsiripakdee, I., Monhaphol, T., Nonthabenjawan, R., & Wanichwecharungruang, S. P. (2007). Post TLC developing technique for tyrosinase inhibitor detection. Biomedical Chromatography, 21(1), 94-100. doi:10.1002/bmc.727
     連結：
141. Wei, Z. H., Duan, Y. Y., Qian, Y. Q., Guo, X. F., Li, Y. J., Jin, S. H., . . . Zhong, J. J. (2014). Screening of Ganoderma strains with high polysaccharides and ganoderic acid contents and optimization of the fermentation medium by statistical methods. Bioprocess and Biosystems Engineering, 37(9), 1789-1797. doi:10.1007/s00449-014-1152-2
     連結：
142. Weng, Y. F., Lu, J., Xiang, L., Matsuura, A., Zhang, Y., Huang, Q. M., & Qi, J. H. (2011). Ganodermasides C and D, two new anti-aging ergosterols from spores of the medicinal mushroom Ganoderma lucidum. Bioscience Biotechnology and Biochemistry, 75(4), 800-803. doi:10.1271/bbb.100918
     連結：
143. Weng, Y. F., Xiang, L., Matsuura, A., Zhang, Y., Huang, Q. M., & Qi, J. H. (2010). Ganodermasides A and B, two novel anti-aging ergosterols from spores of a medicinal mushroom Ganoderma lucidum on yeast via UTH1 gene. Bioorganic & Medicinal Chemistry, 18(3), 999-1002. doi:10.1016/j.bmc.2009.12.070
     連結：
144. Wilson, V. G. (2014). Growth and differentiation of HaCaT keratinocytes. Methods Mol Biol, 1195, 33-41. doi:10.1007/7651_2013_42
     連結：
145. Wu, G. S., Guo, J. J., Bao, J. L., Li, X. W., Chen, X. P., Lu, J. J., & Wang, Y. T. (2013). Anti-cancer properties of triterpenoids isolated from Ganoderma lucidum - a review. Expert Opinion on Investigational Drugs, 22(8), 981-992. doi:10.1517/13543784.2013.805202
     連結：
146. Wu, Q. P., Xie, Y. Z., Deng, Z. Q., Li, X. M., Yang, W. N., Jiao, C. W., . . . Yang, B. B. (2012). Ergosterol peroxide isolated from Ganoderma lucidum abolishes microRNA miR-378-Mediated tumor cells on chemoresistance. Plos One, 7(8). doi:ARTN e4457910.1371/journal.pone.0044579
     連結：
147. Wu, S. Y. S., Wang, H. M. D., Wen, Y. S., Liu, W. T., Li, P. H., Chiu, C. C., . . . Wen, Z. H. (2015). 4-(Phenylsulfanyl)butan-2-one suppresses melanin synthesis and melanosome maturation in vitro and in vivo. International Journal of Molecular Sciences, 16(9), 20240-20257. doi:10.3390/ijms160920240
     連結：
148. Wu, W. H., Hung, W. C., Lo, K. Y., Chen, Y. H., Wan, H. P., & Cheng, K. C. (2016). Bioethanol production from taro waste using thermo-tolerant yeast Kluyveromyces marxianus K21. Bioresource Technology, 201, 27-32. doi:10.1016/j.biortech.2015.11.015
     連結：
149. Xu, J. W., Ji, S. L., Li, H. J., Zhou, J. S., Duan, Y. Q., Dang, L. Z., & Mo, M. H. (2015). Increased polysaccharide production and biosynthetic gene expressions in a submerged culture of Ganoderma lucidum by the overexpression of the homologous alpha-phosphoglucomutase gene. Bioprocess and Biosystems Engineering, 38(2), 399-405. doi:10.1007/s00449-014-1279-1
     連結：
150. Xu, J. W., Xu, Y. N., & Zhong, J. J. (2010). Production of individual ganoderic acids and expression of biosynthetic genes in liquid static and shaking cultures of Ganoderma lucidum. Applied Microbiology and Biotechnology, 85(4), 941-948. doi:10.1007/s00253-009-2106-5
     連結：
151. Xue, Q., Ding, Y. X., Shang, C. H., Jiang, C., & Zhao, M. W. (2008). Functional expression of LZ-8, a fungal immunomodulatory protein from Ganoderma lucidium in Pichia pastoris. Journal of General and Applied Microbiology, 54(6), 393-398.
     連結：
152. Yang, L. B., Zhan, X. B., Zheng, Z. Y., Wu, J. R., Gao, M. J., & Lin, C. C. (2014). A novel osmotic pressure control fed-batch fermentation strategy for improvement of erythritol production by Yarrowia lipolytica from glycerol. Bioresource Technology, 151, 120-127. doi:10.1016/j.biortech.2013.10.031
     連結：
153. Yang, M. H., Lin, Y. J., Kuo, C. H., & Ku, K. L. (2010). Medicinal mushroom Ganoderma lucidum as a potent elicitor in production of t-resveratrol and t-piceatannol in peanut calluses. Journal of Agricultural and Food Chemistry, 58(17), 9518-9522. doi:10.1021/jf102107p
     連結：
154. Yeh, C. H., Chen, H. C., Yang, J. J., Chuang, W. I., & Sheu, F. (2010). Polysaccharides PS-G and protein LZ-8 from Reishi (Ganoderma lucidum) exhibit diverse functions in regulating murine macrophages and T lymphocytes. Journal of Agricultural and Food Chemistry, 58(15), 8535-8544. doi:10.1021/jf100914m
     連結：
155. Yoo, Y. S., Yoo, M. A., Song, Y. K., & Byun, S. Y. (2007). Regulation of proteins related to melanogenesis by heartwood extract of Morus bombycis using proteome analysis. Biotechnology and Bioprocess Engineering, 12(6), 662-667.
     連結：
156. Yoon, N. Y., Eom, T. K., Kim, M. M., & Kim, S. K. (2009). Inhibitory effect of phlorotannins isolated from Ecklonia cava on mushroom tyrosinase activity and melanin formation in mouse B16F10 melanoma cells. Journal of Agricultural and Food Chemistry, 57(10), 4124-4129. doi:10.1021/jf900006f
     連結：
157. You, B. J., Lee, M. H., Tien, N., Lee, M. S., Hsieh, H. C., Tseng, L. H., . . . Lee, H. Z. (2013). A novel approach to enhancing ganoderic acid production by Ganoderma lucidum using apoptosis induction. Plos One, 8(1). doi:ARTN e5361610.1371/journal.pone.0053616
     連結：
158. You, B. J., Tien, N., Lee, M. H., Bao, B. Y., Wu, Y. S., Hu, T. C., & Lee, H. Z. (2017). Induction of apoptosis and ganoderic acid biosynthesis by cAMP signaling in Ganoderma lucidum. Scientific Reports, 7. doi:ARTN 31810.1038/s41598-017-00281-x
     連結：
159. Yue, Q. X., Song, X. Y., Ma, C., Feng, L. X., Guan, S. H., Wu, W. Y., . . . Guo, D. A. (2010). Effects of triterpenes from Ganoderma lucidum on protein expression profile of HeLa cells. Phytomedicine, 17(8-9), 606-613. doi:10.1016/j.phymed.2009.12.013
     連結：
160. Yuen, J. W. M., & Gohel, M. D. I. (2005). Anticancer effects of Ganoderma lucidum: A review of scientific evidence. Nutrition and Cancer-an International Journal, 53(1), 11-17. doi:DOI 10.1207/s15327914nc5301_2
     連結：
161. Yun, W. J., Kim, E. Y., Park, J. E., Jo, S. Y., Bang, S. H., Chang, E. J., & Chang, S. E. (2016). Microtubule-associated protein light chain 3 is involved in melanogenesis via regulation of MITF expression in melanocytes. Scientific Reports, 6. doi:ARTN 1991410.1038/srep19914
     連結：
162. Zhang, C., Lu, Y., Tao, L., Tao, X., Su, X., & Wei, D. (2007). Tyrosinase inhibitory effects and inhibition mechanisms of nobiletin and hesperidin from citrus peel crude extracts. J Enzyme Inhib Med Chem, 22(1), 91-98. doi:10.1080/14756360600988989
     連結：
163. Zhang, L., Ding, Z. Y., Xu, P., Wang, Y. H., Gu, Z. H., Qian, Z., . . . Zhang, K. C. (2011). Methyl lucidenate F isolated from the ethanol-soluble-acidic components of Ganoderma lucidum is a novel tyrosinase inhibitor. Biotechnology and Bioprocess Engineering, 16(3), 457-461. doi:10.1007/s12257-010-0345-z
     連結：
164. Zhang, S. S., Nie, S. P., Huang, D. F., Feng, Y. L., & Xie, M. Y. (2014). A Novel Polysaccharide from Ganoderma atrum Exerts Antitumor Activity by Activating Mitochondria-Mediated Apoptotic Pathway and Boosting the Immune System. Journal of Agricultural and Food Chemistry, 62(7), 1581-1589. doi:10.1021/jf4053012
     連結：
165. Zhang, W. J., Tao, J. Y., Yang, X. P., Yang, Z. L., Zhang, L., Liu, H. S., . . . Wu, J. G. (2014). Antiviral effects of two Ganoderma lucidum triterpenoids against enterovirus 71 infection. Biochemical and Biophysical Research Communications, 449(3), 307-312. doi:10.1016/j.bbrc.2014.05.019
     連結：
166. Zhang, W. X., & Zhong, J. J. (2013). Oxygen limitation improves ganoderic acid biosynthesis in submerged cultivation of Ganoderma lucidum. Biotechnology and Bioprocess Engineering, 18(5), 972-980. doi:DOI 10.1007/s12257-013-0148-0
     連結：
167. Zhao, W., Xu, J. W., & Zhong, J. J. (2011). Enhanced production of ganoderic acids in static liquid culture of Ganoderma lucidum under nitrogen-limiting conditions. Bioresource Technology, 102(17), 8185-8190. doi:DOI 10.1016/j.biortech.2011.06.043
     連結：
168. Zhou, J. S., Ji, S. L., Ren, M. F., He, Y. L., Jing, X. R., & Xu, J. W. (2014). Enhanced accumulation of individual ganoderic acids in a submerged culture of Ganoderma lucidum by the overexpression of squalene synthase gene. Biochemical Engineering Journal, 90, 178-183. doi:10.1016/j.bej.2014.06.008
     連結：
169. Zhou, S., Gao, Y., & Chan, E. (2005). Clinical Trials for Medicinal Mushrooms: Experience with Ganoderma lucidum (W.Curt.:Fr.) Lloyd (Lingzhi Mushroom). 7(1&2), 111-118. doi:10.1615/IntJMedMushr.v7.i12.110
     連結：
170. Zhu, Q. C., Bang, T. H., Ohnuki, K., Sawai, T., Sawai, K., & Shimizu, K. (2015). Inhibition of neuraminidase by Ganoderma triterpenoids and implications for neuraminidase inhibitor design. Scientific Reports, 5. doi:ARTN 1319410.1038/srep13194
     連結：
171. Zon, L. I., & Peterson, R. T. (2005). In vivo drug discovery in the zebrafish. Nature Reviews Drug Discovery, 4(1), 35-44. doi:10.1038/nrd1606
     連結：
172. Zou, X., Sun, M., & Guo, X. (2006). Quantitative response of cell growth and polysaccharide biosynthesis by the medicinal mushroom Phellinus linteus to NaCl in the medium. World Journal of Microbiology & Biotechnology, 22(11), 1129-1133. doi:10.1007/s11274-006-9153-1
     連結：
173. Bhosle, S., Ranadive, K., Bapat, G., Garad, S., Deshpande, G., & Vaidya, J. (2010). Taxonomy and diversity of Ganoderma from the western parts of maharashtra (India). Mycosphere, 1(3), 249-262.
174. Chen, S. L., Xu, J., Liu, C., Zhu, Y. J., Nelson, D. R., Zhou, S. G., . . . Sun, C. (2012). Genome sequence of the model medicinal mushroom Ganoderma lucidum. Nature Communications, 3. doi:ARTN 91310.1038/ncomms1923
175. Deri, B., Kanteev, M., Goldfeder, M., Lecina, D., Guallar, V., Adir, N., & Fishman, A. (2016). The unravelling of the complex pattern of tyrosinase inhibition. Scientific Reports, 6. doi:ARTN 3499310.1038/srep34993
176. Jutti Levita, Keu Heng Chao, & Mutakin. (2014). Interactions of Ganoderiol-F with aspartic proteases of HIV and plasmepsin for anti-HIV and anti-malarial discovery. International Journal of Pharmacy and Pharmaceutical Sciences, 6(5), 561-566.
177. Li, J. R., Cheng, C. L., Yang, W. J., Yang, C. R., Ou, Y. C., Wu, M. J., & Ko, J. L. (2014). FIP-gts potentiate autophagic cell death against cisplatin-resistant urothelial cancer cells. Anticancer Research, 34(6), 2973-2983.
178. Lv, G. P., Zhao, J., Duan, J. A., Tang, Y. P., & Li, S. P. (2012). Comparison of sterols and fatty acids in two species of Ganoderma. Chemistry Central Journal, 6. doi:Artn 1010.1186/1752-153x-6-10
179. Mukaiyama, T., Tsujimura, N., Otaka, S., Kosaka, Y., Hata, K., Hori, K., & Sakamoto, K. (2009). Anti-melanogenic activity of ergosterol peroxide from Ganoderma lucidum on a mouse melanoma cell line. In S. Shirahata, K. Ikura, M. Nagao, A. Ichikawa, & K. Teruya (Eds.), Animal Cell Technology: Basic & Applied Aspects (Vol. 15, pp. 273-277): Springer Netherlands.
180. Tan, N. Z., Gao, L., Xu, C., Yang, J. Y., Zhang, Y., Zhao, C. S., . . . Zhu, J. S. (2014). Ganoderma lucidum ReishiMax restored aging-related changes in expressions of multiple gene pathways in normal aging mice. Faseb Journal, 28(1).
181. Wagner, R., Mitchell, D. A., Sassaki, G. L., Amazonas, M. A. L. D., & Berovic, M. (2003). Current techniques for the cultivation of Ganoderma lucidum for the production of biomass, ganoderic acid and polysaccharides. Food Technology and Biotechnology, 41(4), 371-382.
182. Zhang, N., Yin, Y., Xu, S. J., Wu, Y. P., & Chen, W. S. (2012). Inflammation & apoptosis in spinal cord injury. Indian Journal of Medical Research, 135(3), 287-296.